Currently, two vaccines - Covishield and covaxin - are being used in the ongoing vaccination campaign against Corona in India. A third vaccine may be added soon. This Russian vaccine is expected to be Sputnik V. Dr Reddy's Laboratory, a Hyderabad-based company in India, is conducting its trials and is expected to approach the drug regulator in March for emergency approval. This vaccine will be available in India for $ 10 (about Rs 730).
Of the 10 vaccines approved worldwide, Sputnik V as well as the vaccines of American companies Pfizer and Mordana have proved to be more than 90% effective. For this reason, the fight against Corona can be expected to be strengthened with the availability of the Russian vaccine in India. The Russian vaccine has been created by the Gamalaya Institute of Russia and funded by the Russian Direct Investment Fund (RDIF). RDIF is also doing the deal on this vaccine from around the world.
RDIF CEO Kirill Dmitriev said that the price of the Moderna and Pfizer vaccines, which currently prove more than 90% efficacy, is three times the price of Sputnik V. With this, the Russian vaccine is being tried to reach more and more countries all over the world. The good thing is that it can be stored at a temperature of 2 to 8 ° C which is readily available in the current supply chain. The Russian vaccine is composed of two adenovirus vectors. The company is currently in talks with British firm AstraZeneca on combined trials with its vaccine - CoveShield. The company claims that the effectiveness of the AstraZeneca vaccine will increase further.
India will have the most effective and affordable vaccine
If the Russian vaccine is successful in all trials and is approved in India, it will be the most effective vaccine in trials. The efficacy of the Covishield vaccine being used in India has been 70%, while the phase-3 trials of Covaxin have not been completed yet. Because of this, the situation regarding its effectiveness is not clear.
The government is getting one dose of Covshield for 200 rupees and one dose of Covaxin for 295 rupees. At the same time, CoviShield's dose in the market will be Rs 1,000. Covaxin has not yet disclosed the market price. In such a situation, Sputnik V priced at Rs 730 can be the cheapest and effective vaccine in the market.
Which countries have received approval so far
Dimitrev said Sputnik V has so far received approval in Russia, Belarus, Serbia, Argentina, Bolivia, Algeria, Palestine, Venezuela, Paraguay, UAE, Turkmenistan. Hungary has become the first country in the European Union to approve it. Approval can be obtained soon from the Drug Regulator of the European Union.
The Central Government on Wednesday (November 27, 2024) told the Lok Sabha that a total of 58,929
Nowadays you can see many babas on social media. More than half of them are playing with the emot
There are only a few days left for the T20 World Cup to begin. All the teams are busy preparing f
Prime Minister Narendra Modi will present Chamba Rumal, Kangra Miniature Paintings, Kinnauri Shaw
Himachal Kullu Tourists Accident, Himachal Pradesh A group of 17 people who went to visit Jalori
US President Joe Biden held talks with Chinese President Xi Jinping via video conferencing late o
Military helicopters attacked a school in Myanmar. 13 people died in the attack, including 7 chil
Loud explosions were heard in Ukraine's capital Kyiv and surrounding areas in the early hours of
The audience is eagerly waiting for 'Fukrey 3', the third installment of the 'Fukrey' franchise.
Is the Russian President sick in the Ukraine war? Mysterious black marks visible on Putin's hand
The health of Russian President Vladimir Putin is once again in the news. The reason behind this
